Clinical trial
Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
NCT00040378
Study timeline
Study start (actual)2002-05-01Date precision: month
Registry last updated2018-03-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Interventions
alphatocopherolDRUG
SeleniumDRUG · verified · RxNorm: selenium
Sponsors & collaborators
Frederick Schmittlead sponsor
National Institute on Aging (NIA)collaborator
National Cancer Institute (NCI)collaborator
Mapped research locations
San JuanPuerto Rico6ToledoOhio, United States4SeattleWashington, United States3Washington D.C.District of Columbia, United States3OmahaNebraska, United States3SpringfieldMissouri, United States2DallasTexas, United States1NashvilleTennessee, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1ColumbusOhio, United States1JacksonvilleFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00040378 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.